
ORENCIA
ABATACEPT
- Strength
- 125mg/250mg
- Manufacturer
- BRISTOL-MYERS SQUIBB Pharma
- Availability
- Available to source
ABATACEPT 125mg/250mg — Injection, 1's Vial
Need assistance?
Our multilingual healthcare support team can help with availability, shipping and ordering.
Chat on WhatsApp
Scan for WeChat
About this medicine
Originator: ORENCIA by Bristol-Myers Squibb Company. · Manufacturer: BRISTOL-MYERS SQUIBB Pharma. Indication & Dosage: ORENCIA (ABATACEPT), is a prescription medication used to treat of autoimmune diseases such as moderate to severe rheumatoid arthritis, psoriatic arthritis, and polyarticular juvenile idiopathic arthritis. It works by selectively modulating the immune response through inhibition of T-cell activation, thereby reducing inflammation, joint damage, and other symptoms associated with these chronic inflammatory conditions. ORENCIA Manufactured by BRISTOL MYERS SQUIBB Pharma Ltd. in USA. Abatacept is administered by a healthcare professional as an intravenous infusion over approximately 30 minutes, initially at weeks 0, 2, and 4, followed by maintenance doses every 4 weeks thereafter. Side Effects: The most common adverse reactions are: Headache, nausea, cough, dizziness, and mild injection site reactions such as redness, itching, or pain. The above information comes from the Internet. Please consult with doctor for medical advice.
Indications
This information is provided for reference only and is not medical advice. Always consult a qualified healthcare professional.



